These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 32940174)
1. Oncogenic LncRNA CASC9 in Cancer Progression. Qi Y; Song C; Zhang J; Guo C; Yuan C Curr Pharm Des; 2021; 27(4):575-582. PubMed ID: 32940174 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer. Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984 [TBL] [Abstract][Full Text] [Related]
5. lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR‑195/497 cluster. Shao G; Wang M; Fan X; Zhong L; Wang Z; Zhang P; Ji S Int J Oncol; 2019 May; 54(5):1665-1675. PubMed ID: 30816435 [TBL] [Abstract][Full Text] [Related]
6. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer. Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036 [TBL] [Abstract][Full Text] [Related]
7. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945 [TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer. Pan Z; Mao W; Bao Y; Zhang M; Su X; Xu X Cancer Med; 2016 Sep; 5(9):2442-7. PubMed ID: 27431358 [TBL] [Abstract][Full Text] [Related]
9. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340 [TBL] [Abstract][Full Text] [Related]
10. Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance. Shang C; Sun L; Zhang J; Zhao B; Chen X; Xu H; Huang B Oncotarget; 2017 Feb; 8(9):15393-15398. PubMed ID: 28146436 [TBL] [Abstract][Full Text] [Related]
11. The Long Noncoding RNA Cancer Susceptibility Candidate 9 Promotes Nasopharyngeal Carcinogenesis via Stabilizing HIF1α. Su X; Li G; Liu W DNA Cell Biol; 2017 May; 36(5):394-400. PubMed ID: 28398871 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis. Li C; Zhang J; Zhou Y; Li B Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. Zhou J; Xiao H; Yang X; Tian H; Xu Z; Zhong Y; Ma L; Zhang W; Qiao G; Liang J Sci Rep; 2018 Jan; 8(1):37. PubMed ID: 29311567 [TBL] [Abstract][Full Text] [Related]
14. GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells. Xi J; Wang Y; Liu H Gene; 2020 Feb; 726():144194. PubMed ID: 31669650 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA (LncRNA) CASC9/microRNA(miR)-590-3p/sine oculis homeobox 1 (SIX1)/NF-κB axis promotes proliferation and migration in breast cancer. Chang J; Zhang Y; Ye X; Guo H; Lu K; Liu Q; Guo Y Bioengineered; 2021 Dec; 12(1):8709-8723. PubMed ID: 34711117 [TBL] [Abstract][Full Text] [Related]
16. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation. Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p. Zhang T; Yang J; Gong F; Li L; Li A Cell Cycle; 2020 Sep; 19(18):2270-2280. PubMed ID: 32772636 [TBL] [Abstract][Full Text] [Related]
18. The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling. Klingenberg M; Groß M; Goyal A; Polycarpou-Schwarz M; Miersch T; Ernst AS; Leupold J; Patil N; Warnken U; Allgayer H; Longerich T; Schirmacher P; Boutros M; Diederichs S Hepatology; 2018 Nov; 68(5):1817-1832. PubMed ID: 29790588 [TBL] [Abstract][Full Text] [Related]
19. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CASC9 enhances breast cancer progression by promoting metastasis through the meditation of miR-215/TWIST2 signaling associated with TGF-β expression. Zhang J; Wang Q; Quan Z Biochem Biophys Res Commun; 2019 Aug; 515(4):644-650. PubMed ID: 31178137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]